MYC and cancer: FOXM1 is upregulated during early cancer development, and contributes to tumorigenesis through stimulation of cell cycle progression via direct proliferation-driving targets like c-Myc [39, 49, 50], and suppression of senescence [20] that can lead to cancer cell survival and relapse.